Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
19/03/2026 12:01
March 19 (Reuters) - Armata Pharmaceuticals Inc ARMP.A: ARMATA PHARMACEUTICALS DELAYS ANNOUNCEMENT OF FOURTH QUARTER AND FULL-YEAR 2025 RESULTS AND PROVIDES CORPORATE UPDATE Source text: ID:nPn7lfHwwa Further company coverage: ARMP.A ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles